Aardvark Therapeutics has followed up filings and speculation with a $94 million initial public offering, putting itself on ...
In this episode, presented by the Genscript Biotech Global Forum 2025, BioSpace's Head of Insights Lori Ellis and Tom ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback